KEYBANK NATIONAL ASSOCIATION/OH - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.

Quarter-by-quarter ownership
KEYBANK NATIONAL ASSOCIATION/OH ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$387,998
+9.9%
9,683
+11.9%
0.00%0.0%
Q1 2023$353,129
+4.8%
8,653
-0.8%
0.00%0.0%
Q4 2022$336,950
-22.7%
8,727
+6.5%
0.00%0.0%
Q3 2022$436,000
+19.1%
8,197
+30.7%
0.00%0.0%
Q2 2022$366,000
-27.1%
6,273
-4.6%
0.00%0.0%
Q1 2022$502,000
+27.1%
6,575
+0.3%
0.00%0.0%
Q4 2021$395,000
+7.6%
6,5570.0%0.00%0.0%
Q3 2021$367,000
-7.8%
6,5570.0%0.00%0.0%
Q2 2021$398,000
-56.7%
6,557
-50.0%
0.00%0.0%
Q1 2021$920,000
+134.1%
13,114
+99.9%
0.00%0.0%
Q4 2020$393,000
-0.3%
6,5600.0%0.00%0.0%
Q3 2020$394,000
+14.9%
6,560
+0.4%
0.00%0.0%
Q2 2020$343,000
+57.3%
6,533
+0.5%
0.00%
+100.0%
Q1 2020$218,000
-43.1%
6,500
-23.2%
0.00%
-50.0%
Q4 2019$383,000
+19.3%
8,462
+0.2%
0.00%0.0%
Q3 2019$321,000
-13.0%
8,445
-0.5%
0.00%0.0%
Q2 2019$369,000
+14.2%
8,4850.0%0.00%0.0%
Q1 2019$323,000
-10.5%
8,485
+1.2%
0.00%0.0%
Q4 2018$361,000
-12.6%
8,387
-0.3%
0.00%0.0%
Q3 2018$413,000
+53.0%
8,4110.0%0.00%0.0%
Q2 2018$270,000
+3.1%
8,4110.0%0.00%0.0%
Q1 2018$262,000
-31.8%
8,4110.0%0.00%0.0%
Q4 2017$384,0008,4110.00%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders